Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jan 22, 2023 1:44am
321 Views
Post# 35238235

RE:somethings gotta give...

RE:somethings gotta give...

Yajne wrote: I've gotta believe that TLT hasn't shown all of their cards to address the financing issue that's soon approaching. My math suggests they raised enough pp funds to get to the end of Q1 (Mar31/23). They must already know of a JV in the works or something to remain solvent past Q1. I'm optimistic that there is a game plan in the works, but something definitely has gotta give soon...GLTA all longs!!

 

Yep...Big Pharma will flex its $ leverage regardless of partnership type, but would rather have them flex leverage in the form of a JV.  They would certainly otherwise be looking for a fire sale buyout price at this juncture.  It's going to be a tight race between two timelines:  BTD/sp increase & the need for cash...let's hope the former finishes first.

<< Previous
Bullboard Posts
Next >>